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Like many neurodegenerative diseases, the clinical symptoms of Parkinsons disease
(PD) do not manifest until significant progression of the disease has already taken place,
motivating the need for sensitive biomarkers of the disease. While structural imaging
is a potentially attractive method due to its widespread availability and non-invasive
nature, global morphometric measures (e.g., volume) have proven insensitive to subtle
disease change. Here we use individual surface displacements from deformations of an
average surface model to capture disease related changes in shape of the subcortical
structures in PD. Data were obtained from both the University of British Columbia (UBC)
[n = 54 healthy controls (HC) and n = 55 Parkinsons disease (PD) patients] and the
publicly available Parkinsons Progression Markers Initiative (PPMI) [n = 137 (HC) and
n = 189 (PD)] database. A high dimensional non-rigid registration algorithm was used
to register target segmentation labels (caudate, putamen, pallidum, and thalamus) to a
set of segmentation labels defined on the average-template. The vertex-wise surface
displacements were significantly different between PD and HC in thalamic and caudate
structures. However, overall displacements did not correlate with disease severity, as
assessed by the Unified Parkinson’s Disease Rating Scale (UPDRS). The results from
this study suggest disease-relevant shape abnormalities can be robustly detected in
subcortical structures in PD. Future studies will be required to determine if shape changes
in subcortical structures are seen in the prodromal phases of the disease.
Keywords: LDDMM, shape analysis, surface displacement, Parkinson’s disease, prediction, brain MRI
1. Introduction
Parkinson’s disease (PD) is the second most common age related neurodegenerative disor-
der after Alzheimers disease (de Lau and Breteler, 2006). Routine clinical MRI is rarely used
in diagnosis, and is often used only to rule out other conditions that may mimic PD (e.g.,
vascular Parkinsonism). Although there are no gross structural abnormalities seen in PD,
the use of structural MRI is still potentially attractive as a biomarker because of the ubiq-
uitous nature of the technology. Several studies have suggested subtle morphological alter-
ations such as atrophy in the putamen and/or caudate (Schulz et al., 1999; Ghaemi et al.,
2002; Krabbe et al., 2005; Pitcher et al., 2012). Most of these studies have looked at over-
all volume as a measure of atrophy as it easy to measure, invariant to position of the
subject in the scanner, and, if appropriately normalized, directly comparable across subjects.
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However, in some structures such as the thalamus, volume may
actually increase as a compensatory mechanism when cortical
regions are damaged (Pol and van der Flier, 2000), complicating
overall volume as a marker of disease progression. This may be
why the thalami undergo significant shape change with PD, even
when no significant difference in volume can be detected (McKe-
own et al., 2008), presumably on the basis of specific nuclei being
affected and/or compensatory hypertrophy of other regions.
Commonly-used brain morphometric analysis methods to
assess progression of neurodegenerative disease can be catego-
rized into three general types: voxel-based, surface-based, and
deformation-based methods. By far, the majority of morphom-
etry studies to date have been based on voxel-based morphome-
try (VBM), because of its conceptual simplicity and widespread
availability of suitable software. In VBM, subjects brain images
are registered to a common template image, and statistical anal-
yses are performed on a voxel-by-voxel basis on the registered
subject brain images. This technique has demonstrated cortical
loss in some brain areas in PD (Burton et al., 2005; Nagano-Saito
et al., 2005) and in other PD-related diseases (e.g., Multi system
atrophy) (Paviour et al., 2006; Brenneis et al., 2007; Tzarouchi
et al., 2010). Nevertheless, there is widespread recognition of the
limitations of VBM: it tends to find focal changes as opposed to
more spatially distributed changes (Davatzikos, 2004), and may
be insensitive to subtle morphological alterations (Bergouignan
et al., 2009).
An alternative approach is to use surface-based morphometry
(SBM) for measuring shape changes. In SBM, a surface represen-
tation of a structural boundary is investigated rather than at the
level of the individual voxels. Using such a method, PD related
shape and volume changes in the hippocampus, caudate and
ventricles can be detected (Apostolova et al., 2010). In a similar
approach, deformation-based morphometry (DBM), the defor-
mation fields obtained from one-to-one non-rigid registrations
are analyzed in place of the final registered images (Duchesne
et al., 2009). In our work, we use a SBMmethod where we model
the change in shape as the deformation of a template surface to
the individual target surfaces for the disease and control groups.
The surface displacement metric obtained as a signed normal
component of the displacement vector (from template to target
surface) at each vertex on the template surface captures the defor-
mation information. This metric directly models deformation on
the surface of the template.
Here we present a SBM method that incorporates
anatomically-defined regions of interest (ROIs). Accurate
segmentation labels for subcortical ROIs were obtained via an
automated registration based segmentation process (Khan et al.,
2008). These labels were then registered to a prototype via a
non-linear registration algorithm (Beg et al., 2005). The template
for this study was generated via an alternating registration
and averaging process (Khan and Beg, 2009), that encapsulates
information from the entire cohort and thus with minimal bias to
data from a specific subject. Given a mean template, the surface
displacement obtained from taking the difference in coordinates
between the reference (template) and the deformed surfaces on a
vertex-by vertex basis represent a feature for subsequent classifi-
cation. Based on prior work (McKeown et al., 2008; Apostolova
et al., 2010) we study the change in shape of caudate, thalamus,
putamen, and pallidum structures due to PD. We processed the
imaging data from two cohorts with PD patients and healthy
control groups, and analyzed the surface displacement feature
for the group level difference in the features.
The rest of the paper is organized as follows: in Section 2
the data and processing methods are introduced, followed by
the results of experiments in Section 3. The results are further
discussed and concluded in Section 4.
2. Materials and Methods
In this section we discuss the methods for extraction of shape fea-
tures from the MRI data for the individual subcortical ROIs. The
feature extraction process consists of a number of steps applied
sequentially to perform the tasks of data pre-processing, con-
struction of a prototype, diffeomorphic registration followed by
final feature extraction. These features are then tested for differ-
ences between the PD andHC groups. The following sub-sections
provide a description of these steps in detail.
2.1. Subjects and Scans
2.1.1. University of British Columbia (UBC) Dataset
Data were taken from 55 non-demented PD subjects and 54
healthy subjects seen at theUBC Pacific Parkinson’s Research Cen-
ter. Table 1 gives the clinical and demographic details of the PD
and control groups.Written informed consent was obtained from
all subjects prior to participation in the study. This study was
approved by the Clinical Research Ethics Board of the University
of British Columbia and conforms to the Declaration of Helsinki.
Patients were examined after overnight medication with-
drawal with >12 h for L-dopa and >18 h for dopamine ago-
nists. Exclusion criteria included atypical parkinson’s (cerebellar
ataxia, prominent dementia, early postural instability), symmet-
rical onset of symptoms, evidence of severe memory impairment
or signs of dementia [Montreal Cognitive Assessment (MoCA)
scores <24] or a history of cerebrovascular disease or other neu-
rological disorders. The Unified Parkinson’s Disease Rating Scale
(UPDRS) motor scale data were recorded and used in further
analysis.
Subjects were scanned using a Philips Achieva 3.0 T scanner
(Philips, Best, The Netherlands), with a 8-channel head coil. A
memory foam pillow was used to minimize head motion. The
acquisition parameters for the 3D T1-TFE sequence were as fol-
lows: 170 axial slices, repetition time = 7.7ms, echo time =
3.6ms, flip angle 8◦, field of view 256× 200 mm, acquired matrix
size 256× 200, and voxel size 1× 1× 1 mm3.
TABLE 1 | Demographics for the data in the UBC dataset.
Variable Healthy control PD subjects
Number 54 55
Age 46.16 ± 16.80 64 ± 8.11
Gender 23M/25F 36M/19F
UPDRS N.A. 25.89 ± 11.02
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2.1.2. Parkinson’s Progression Marker Initiative
(PPMI) Cohort
The data available under the PPMI project was obtained from
the LONI Image data archive (https://ida.loni.usc.edu). The data
acquisition details are available on the website for the PPMI
project and can be obtained from the url (http://www.ppmi-info.
org/). The data from the baseline visit was selected for the analy-
sis. We randomly chose a subset of subjects so that they would be
age-matched with other subject groups. The demographic details
for this subset are presented in the Table 2.
The PPMI cohort is a multicenter study where multiple scan-
ners and imaging protocols are used. An example protocol for a
MPRAGE sequence as used in the study is as follows: Siemens
Magnetom TrioTim sungo MR B17 3T scanner (Siemens, Ger-
many). T1 weighted images were acquired with the MPRAGE
sequence with the following parameters: 176 axial slices, repeti-
tion time= 2300ms, echo time= 2.98ms, flip angle= 9◦, field of
view= 256mm, acquired matrix size= 256×200, and voxel size
1×1×1 mm3. Some other scanners used in the study include GE
Signa 3.0T, GE Discovery 3.0T (G.E., USA), Philips Acheiva 1.5T
(Philips, Netherlands), Siemens TrioTim 3.0T, Siemens Sym-
phony 1.5T, Siemens Verio 3.0T, Siemens Espree 1.5T (Siemens,
Germany). Extensive pre-processing and data normalization was
performed by the members of the PPMI-core group prior to
release of the data for public use. For detailed image acquisi-
tion protocols and scanner specific preprocessing the reader is
referred to the website of the PPMI cohort at www.ppmi-info.org
2.2. Data Analysis Process
In this section, we present the details of the image analysis
steps that was used to obtain the surface displacement data
for individual subcortical structures from the raw MRI data.
We briefly describe the registration algorithm, followed by
the methods for segmentation of anatomical structures, pro-
totype creation and surface displacement computation. The
process flow diagram (Figure 1) illustrates the stages of the
process.
2.2.1. Large-Deformation Diffeomorphic Metric
Mapping (LDDMM)
Diffeomorphic registration methods are desirable in processing
of medical imaging data because of their inherent smoothness
and ability to model large and small displacements. Here we
briefly describe the LDDMM (Beg et al., 2005) process, which
generates a diffeomorphic transformation by minimizing the
difference between the source and transformed target images.
TABLE 2 | Demographics for the data in the PPMI dataset.
Variable Healthy control PD patients
Number 137 189
Age 63.85 ± 7.46 68.02 ± 4.77
Gender 75M/62F 115M/74F
UPDRS N.A. 33.62 ± 13.36
Let us define  ⊂ R3 as the coordinate space of the source
image, andG:↔  as the set of diffeomorphic transformations
on . The LDDMM algorithm seeks a geodesic φ : [0, 1] → G
where each point φt ∈ G, t ∈ [0, 1] is a diffeomorphism on the
domain . Then the source image I0 evolves along the path to
the target image I1 according to φtI0 = I0 ◦ φ
−1
t . At the end-
point t = 1, the source I0 is connected to the target image via
I1 = φ1I0 = I0 ◦ φ
−1
1 . The associated velocity field v, taken from
the space of smooth velocity fields V on the domain  ⊂ R3,
is a solution to the differential equation φ˙t = vt(φt), t ∈ [0, 1]
satisfying
vˆ = v : φ˙t
= arg minVt(φt)
(∫ 1
0
‖vt‖
2dt +
1
σ 2
‖I0 ◦ φ
−1
1 − I1‖
2
L2
)
(1)
By integrating the optimizer vˆ of this cost function we get the
optimal change of coordinates ϕ = φvˆ1 . The superscript v in φ
v
is used to explicitly denote the dependence of φ on the associated
velocity field v. The mapping ϕ = φvˆ1 is guaranteed to be a diffeo-
morphism by enforcing sufficient smoothness on the elements of
V . We do this by defining a norm on V through a 3× 3 differen-
tial operator L of the type L = (α1 + γ )αI3×3 where α > 1.5 in
3D space such that ‖f ‖V = ‖Lf ‖L2 , and ‖ · ‖L2 is the standard L2
norm for the square integrable functions defined on . The gra-
dient of the cost function (Equation 1) is given by the following
Freche derivative in V :
∇vEt = 2vˆt − K
(
2
σ 2
|Dφvˆt,1|∇J
0
t (J
0
t − J
1
t )
)
(2)
Where J0t = I0 ◦ φt,0 and J
1
t = I1 ◦ φt,1, |Dg| is the determinant
of the Jacobian matrix and K is a compact self-adjoint operator
K : L2(,R
3) → V uniquely defined by 〈a, b〉L2 = 〈K a, b〉V
such that for any smooth vector field f ∈ V, k(L†L)f = f holds.
Also L† is the adjoint of L and the notation φs,t = φs · φ−1j is
employed. Finally the parameter 1
σ 2
provides weighted optimiza-
tion between the regularization and data matching components,
and is chosen to be the same for all matchings.
In order to compute v, this variational gradient is used in the
standard gradient descent procedure, yielding the update vn+1 =
vn − ε∇vnE where n denotes the simulation number.
The optimal mapping φ0,1 is used in further steps to transform
the images from the source space to the target image space.
2.2.2. FS + LDDMM Segmentation
The FS + LDDMM segmentation steps (Khan et al., 2008) com-
bine the probabilistic labels obtained from the FreeSurfer (FS)
program along with the LDDMM registration with ground truth
template data, to create accurate labels for the subcortical ROIs
in the target MRI data.
Freesurfer (v4.5.0) (Fischl et al., 2002) was utilized to obtain
initial segmentation of subcortical structures for each MRI image
volume. With this process, non-brain tissue was removed from
the images, followed by automated Talairach transformation and
segmentation of caudate, pallidum, putamen, thalamus (Fis-
chl et al., 2002; Fischl and Kouwe, 2004). Subsequently, an
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FIGURE 1 | A process flow diagram for the computation of the surface displacement feature from the raw MRI data.
ROI was defined for each structure on the target and tem-
plate MR images using FS labels and manual labels, respec-
tively. These ROIs from target images were then aligned via an
intensity-based affine transformation to those in the template
images. A bounding box, predefined in the template space using
the extent of the template FS labels plus a 12-voxel padding,
was used to generate sub-volumes. These pre-processed MRI
sub-volumes were then registered via the LDDMM method as
described above (Section 2.2.1) to obtain the final segmentation
labels.
Within the FS + LDDMM process, the LDDMM registration
was performed in a multi-stage fashion, each stage using differ-
ent image pairs and with each subsequent stage initialized with
the velocity vector fields, of the previous stage. In the first stage,
the FS labels of the hippocampus, amygdala, and lateral ventri-
cles were used, in the second stage, Gaussian smoothed (σ = 5)
MRI images were used, and in the final stage non-smoothed MRI
images were used. The velocity vector fields were discretized into
5 timesteps. Finally, the atlas segmentations for each hemisphere
were propagated to the target by applying the LDDMMand affine
transformation, using linear interpolation to maintain precision
when resampling the segmentations. The propagated segmen-
tations from each template were fused with equal weights for
each template. This resulted in a binary segmentation volume
with the same dimensions and orientation as the original MRI
in the native image space with each subcortical region of interest
represented by a voxel intensity of 1 (intensity threshold= 127.5)
and background intensity as 0.
The templates for segmentation of the MRI images in this
study were obtained bymanual segmentation of 6 healthy control
subjects from the UBC scanner but not included in this study.
The protocols for definition of structural boundaries for all the
structures of interest were obtained from previously published
work (Hammers et al., 2003).
2.2.3. Segmentation Quality Check
The final labeling for each structure obtained from the segmen-
tation process was checked for segmentation accuracy through
an extensive quality control process. A surface model was fit
for each binary segmentation volume via the marching cubes
algorithm to provide a set of vertices and triangles represent-
ing the segmentation boundaries. These surfaces were overlayed
on the original MRI images in the three orthogonal views to
check for accuracy of segmentation labels (e.g., Figure 2). A
visual verification of each such visualization was performed by
an expert in neuro-anatomy. In conventional quality control
approaches, the subjects with inaccurate segmentation for any
structure are removed from the subsequent analysis. In our work,
all subjects were found to have accurate segmentation labels and
were included in the subsequent analyses. The demographics
reported in Tables 1, 2 present the set of subjects with accurate
and acceptable segmentation labels. The detailed visualizations
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FIGURE 2 | Saggital upper left Coronal upper right Axial lower left views of the segmentation outlines overlayed on the corresponding MRI slices. The
3D surface renderings show the smooth surfaces lower right.
for all the subjects in the analysis are available at the website
(www.autobrainmapping.com).
2.2.4. Unbiased Average Template (prototype)
Generation
The choice of template for registration influences the accu-
racy of the surface displacement data. To this end we cre-
ated a “prototype” for the cohort (an average template) from
the binary segmentation labels obtained for individual struc-
tures (Khan and Beg, 2009). Pre-processed data were obtained
by affine alignment of each binary subcortical image to an ini-
tial template, followed by extraction of a sub-volume ROI in
the prototype space. The process alternated between (1) reg-
istration (LDDMM) of individual ROIs to a template ROI
and (2) computation of an average from the registered ROIs
in the template space. The average computed in the previous
step formed the template for registration in the next step. A
healthy control subject was chosen as an initial template and
the pipeline was run for three iterations to obtain the final,
average unbiased template. A subset of normal subjects (n =
10) from the UBC dataset were selected for creation of the
prototype.
2.2.5. Surface Displacement
The prototype generated above (Section 2.2.4) was used for com-
putation of the surface displacement data. The target binary
labels were pre-registered to the prototype prior to non-rigid
registration. Two different approaches were considered for the
pre-registration step: (1) using a 6 degrees-of-freedom (DOF)
rigid transformation (2) using a 9 DOF affine transformation.
The rigid pre-registration approach corrects only for the transla-
tional and rotational discrepancies between the target structures,
whereas the affine approach corrects the scale discrepancy as well.
Both pre-registered sets (rigid and affine) were further used in the
pipeline to extract two sets of the surface displacement features.
High dimensional non-rigid registration (LDDMM) from the
prototype segmentation image, Mavg , to each pre-registered seg-
mentation image Mj was performed to obtain the mapping
φMavg ,Mj = LDDMM(Mavg,Mj). The injected-surface was then
computed as Ŝi = φ
−1
Mavg ,Mj
(S), where each Ŝi has the same set of
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corresponding nodes, obtained from the template mesh, S, and
thus all segmentations from different subjects can be compared
at a vertex-wise level. One benefit of this surface injection tech-
nique is that it can deal with many types of topological defects
that can be present in the automated segmentation by enforcing
a smoothness in the deformation that ignores holes and handles,
as has been previously suggested (Khan et al., 2008).
The vertex-wise correspondence in the meshes for each sub-
cortical ROI across subjects enables the quantification of the
disease related atrophy or hypertrophy on the surface of the
ROI. The deformed surfaces may lie inside (atrophy) or outside
(hypertrophy) of the prototype surface. To achieve this we used
a signed closest point distance metric computed at each vertex
on the prototype surface to that on the target surface. At each
node, a ∈ Ŝi, m ∈ S, we find the dot-product of the displace-
ment from prototype to the deformed injected surface,
−→
d m,a
and the surface normal on the average, −→n m. The normal dis-
tance, dnorm(m, a) =
−→
d m,a ·
−→n m is negative or positive when
the deformed surface is respectively inward or outward relative
to the average, effectively an indication of the deformation.
2.3. Statistical Analysis
In this section we describe the methods for the statistical analy-
sis of the volume data and surface displacement features with the
aim to find the group level differences in the data. Volume dif-
ference would suggest a global morphological alteration whereas
surface displacement difference would suggest a localized shape
change as a disease effect. The statistical tests for the surface
displacement data were performed using both the rigidly and
affinely pre-registered surfaces.
2.3.1. Volume: Group Difference
The volume measurements from the surfaces generated from
segmentation labels were tested for the statistical differences
between the PD and HC groups. A two-tailed t-test was per-
formed between the data from the two groups. The significance
level was maintained at p <0.05 for all tests. The test was repeated
for both UBC and PPMI cohorts.
2.3.2. Surface Displacement Data: Group Difference
The surface displacement data as described in the Section 2.2.5
provided a signed distance value at each vertex on the prototype
surface for individual structures. The surfaces for each target sub-
ject were in vertex-to-vertex correspondence enabling a direct
comparison of the displacement data. A vertex-wise compari-
son of group difference across the cohort between the patient
and healthy control groups provided insight into the spatially-
localized, disease-related alteration in shape of the subcortical
structures.
A linear model was fit to regress out the effect of variation in
age and gender effects from the SD data. The SD data were kept
as the outcome variable and the age and gender were used as pre-
dictors in the model. The residuals from the linear model fit were
used in the statistical analysis to test for the effect of disease on the
data. Vertex wise group difference analysis was conducted using
SurfStat software (Worsley et al., 1996), which employs Random
Field Theory to correct for multiple comparisons (Worsley et al.,
2004). The vertex wise comparison and cluster-forming thresh-
olds were set at p <0.05. The contrast between the two groups was
evaluated asHC—PD, where a positive t-value suggested atrophy
in patients in comparison to the healthy controls and vice versa.
2.3.3. Relationship with Clinical Score
The surface displacement data were then tested for their potential
to predict the UPDRS scores in both the studies.
The surface displacement data were rearranged into a 1-
dimensional vector for each structure. These displacement vec-
tors for all structures were then concatenated into a long column
vector for each subject. In order to avoid the curse of dimen-
sionality (very large dimensional data in a small sample size),
dimensionality reduction was performed using Principal Com-
ponent Analysis (PCA) decomposition. Sufficient number of PCs
were retained to account for 95% of the variability in the data.
The PC loadings were tested for the potential to predict the clini-
cal scores in a linear model via linear regression. A leave-one-out
procedure was conducted where each patients’ score was pre-
dicted based on the model fit to the data from the remainder of
the patient group. The PC loadings were the predictors and the
clinical score were the response variables. A 2-D scatter plot (e.g.,
Figure 6) between the predicted vs. the actual score was obtained
and a least squares line was fit to check for statistically significant
relationship between the two. The coefficients of the linear model
and their statistics are reported.
The UPDRS score in the UBC and PPMI cohorts was tested
for association to the surface displacement data. We tested the
UPDRS scores to be normally distributed via a lilleofors test
(Lilliefors, 1967). The data rejected the null hypothesis of “not
normally distributed.”
3. Results
The processed MRI data provided segmentation of subcortical
structures for the caudate, putamen, thalamus, and pallidum
in the left and right hemispheres (Figure 2). The segmentation
labels for the anatomical structures were thoroughly checked
for accuracy via visualization of surface outlines overlayed on
the MRI slices (Figure 2). In our data, all subjects in the two
cohorts were found to have acceptable (surface outline follow-
ing structure boundary) and accurate segmentation labels, and
were retained for subsequent analysis. Similarly, the surface dis-
placement computed for each structure was visualized to check
for presence of inaccuracies (extreme displacement values) due
to registration errors. As an example, visualizations for three
subjects in the patient and control groups are presented for the
caudate and pallidum (right), and putamen and thalamus (left)
structures (Figure 3).
The volumes of structures were significantly different (p <
0.05) for the right thalamus (p = 0.034, t = 2.15), right putamen
(p = 0.041, t = 2.07), and left thalamus (p = 0.035, t = 2.14)
in the UBC dataset. In contrast, volumes in the PPMI dataset
did not present a statistically significant difference for all struc-
tures (Table 3). In the rigid pre-registration case, the vertex-wise
group analysis did not show any statistically significant differ-
ence. However, in the affine pre-registration case, the analysis of
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FIGURE 3 | Visualization for the quality control of the surface
displacement data. Data for three representative subjects from the healthy
control and patients groups, respectively have been presented from the UBC
dataset for left thalamus and caudate and right pallidum and putamen
structures. Color (legend) represents surface displacement from the
prototype surface.
the surface displacement data found vertex clusters with signifi-
cant difference in the displacements between patient and control
groups (Figures 4, 5). As the rigid pre-registration failed to high-
light the significant differences between the CN and PD groups,
we present the results from only the affine case in the rest of
this paper. Disease-related shape changes in subcortical struc-
tures were widespread.Table 4 presents the top 2 clusters ordered
by the residuals of the model fit with their number of vertices,
average t-value, and p-value for each structure.
Spatial clusters with statistically significant difference in the
surface displacement feature in the two groups were found on all
the structures. Two key observations appear from the statistical
comparisons: (1) Structures with net-inward deformation for the
PD group (+ve t-value, right putamen, right, and left pallidum)
and (2) structures with both net-inward and outward deforma-
tion for the PD group (−ve and+ve t-value, left thalamus, right,
and left caudate). Additionally, similar spatial locations with dif-
ference of same (+ve or−ve t-value) nature were observed in the
two datasets (e.g., right and left pallidum). The clinical score pre-
diction experiment with the data from all structures used simul-
taneously as a single column vector was not able to predict the
UPDRS scores with the statistical significance (p > 0.5).
4. Discussion
Analysis of local shape change in comparison to global measures
of morphology highlights the importance of examining spatially-
localized alterations as a disease-related effect. In an extrinsic
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TABLE 3 | Results for the analysis of group level difference in the volume
of the subcortical structures between the participants in the Parkinson’s
disease and healthy control groups.
UBC PPMI
Structure p-value t-stat p-value t-stat
L-thal 0.035* 2.14 0.406 0.83
R-thal 0.034* 2.15 0.180 1.35
L-caud 0.347 −0.95 0.262 −1.12
R-caud 0.092 −1.70 0.053 −1.94
L-pall 0.581 −0.55 0.227 −1.21
R-pall 0.606 0.52 0.945 0.07
L-put 0.126 1.54 0.959 −0.05
R-put 0.041* 2.07 0.400 0.84
Statistical significance at p < 0.05 marked by asterisk (*).
approach, the features extracted from the deformation fields rely
on the choice of template to which individual images/surfaces are
registered. These features can then be compared between groups
for effect of a disease or clinical intervention. We computed the
surface displacementmetric as the signed closest point distance at
each vertex of the surface model to quantify the net surface defor-
mation. Surface displacement data (affine pre-registered) showed
very strong differences between the two groups for all 4 struc-
tures (Table 4, Figures 4, 5). Such differences were observed in
UBC and the PPMI datasets, where patches of vertex-clusters
were present throughout the surface (Figures 4, 5). Both atro-
phy (positive t-value) and hypertrophy (negative t-value) were
present in the patient group, suggesting compensatory alteration
in shape within the same structure.
It is interesting to note that the volume of the subcortical
structures did not show statistically significant difference for any
of the structures in the PPMI dataset (Table 3). In contrast, many
clusters with statistically significant (p < 0.05) difference in
the surface displacement metric were observed in the vertex-
wise group difference analysis (Table 4, Figures 4, 5). Surface dis-
placement being a local, sensitive measure of shape change is able
to present group level differences. In contrast, the gross measure-
ment of the structural volume is shown to not yield sensitivity to
disease changes. This finding is consistent with previous obser-
vations (McKeown et al., 2008) where volume did not show any
difference between the disease and control group, but a shape
feature was able to show statistically significant results.
4.1. Technical Strengths of the Proposed Analysis
Approach
We applied an automated registration based segmentation
approach (FS + LDDMM) which has been validated to provide
accurate segmentation labels (Section 2.2.2) (Khan et al., 2008).
The application of the automated method with multiple tem-
plates is expected to yield accurate segmentation of the subcor-
tical ROI, unaffected from potential variability due to a manual
labeling procedure. This segmentation method has already been
shown to provide high quality segmentation for segmentation
of caudate, thalamus, putamen, and hippocampus (average dice
coefficient = 0.85). Another validation study in the context of
segmentation of pediatric MRI images found the dice coefficients
of 0.89 for thalamus, 0.89 for caudate and 0.87 for putamen,
thereby emphasizing accurate segmentation results (Garg et al.,
2014).
The choice of templates for segmentation is known to impact
segmentation quality (Garg et al., 2014). In our study, we used
templates (n = 6) from the UBC cohort which were manually
segmented by a neuro-anatomy expert. The templates do dif-
fer from the data in the PPMI cohort, which, in itself, being a
collection of data acquired at different sites, has inherent inho-
mogeneities due to scanner characteristics and acquisition pro-
tocols. In order to ensure good quality segmentation of the data
in the two cohorts we performed thorough segmentation qual-
ity check as explained in Section 2.2.3. All the subjects in the
two cohorts were found to have accurate segmentation labels, and
hence were retained for subsequent analysis. This prevented the
errors in segmentation from propagating into subsequent pro-
cessing and analysis steps. Additionally, the use of an unbiased
prototype (Sections 2.2.4, 2.2.5) to obtain the surface displace-
ment metric ensures that the deformation data is free from bias
toward a subset of the group. Therefore, the statistical outcomes
obtained in our study represent the characteristic differences in
the anatomy captured by the MRI data.
4.2. Strength of the Shape Feature
Structural MRI is a potential marker for alterations observed
in PD as it can assess brain systems associated with motor and
non-motor deficits. It has been shown that less sensitive mea-
sures of change in morphology such as volume presents con-
tradictory results for putamen (e.g., Krabbe et al., 2005; Pitcher
et al., 2012) vs. (Schulz et al., 1999), Ghaemi et al. (2002) and
caudate atrophy (e.g., Pitcher et al., 2012 vs. Schulz et al., 1999;
Ghaemi et al., 2002). Additionally, thalami in PD showed sig-
nificant shape change despite no significant difference in volume
(McKeown et al., 2008). Results from our study are in alignment
with the previous observations where volumes of anatomical
structures did not show a statistically significant change, whereas
widespread shape change was observed as an effect of Parkinson’s
disease. Our shape analysis approach and its derived features con-
tain both global and local shape information and show ability to
capture sensitive disease related shape change in two large and
independent datasets.
Previous work (McKeown et al., 2008) exploring differences in
thalamic shape utilized a SPHARM representation. A recent mor-
phometric analysis (Apostolova et al., 2010) also detected changes
in basal ganglia structures between PD subjects with and with-
out dementia. Apostolova’s method focused on volume, where
the radial distance—an intuitive measure of ROI thickness—was
used as morphometric feature. Similarly, other work (Sterling
et al., 2013) also modeled shape with a SPHARM-PDM repre-
sentation and found areas with significant differences in the cau-
date and putamen structures. In contrast, our work quantified the
shape change with a surface displacement measure at every ver-
tex in the average surface model for each sucortical region. The
high dimensional non-rigid registration algorithm (LDDMM,
Beg et al., 2005) used in this study has been shown to account
for the non-linearity of the anatomical shape space. The metric
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FIGURE 4 | Results for the vertex-wise group difference analysis
of the surface displacement data for the left and right,
caudate and thalamus structures in the UBC and PPMI
datasets. The colored patches represent the t-values in the areas
with statistically significant (p < 0.05) difference between the patient
and healthy control group. Gray colored area had no statistically
significant difference between the groups. Positive t-value represents
lower value in the patient group.
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FIGURE 5 | Results for the vertex-wise group difference analysis
of the surface displacement data for left and right, pallidum
and putamen structures in the UBC and PPMI datasets. The
colored patches represent the t-values in the areas with statistically
significant (p < 0.05) difference between the patient and healthy
control group. Gray colored area had no statistically significant
difference between the groups. Positive t-value represents lower value
in the patient group.
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TABLE 4 | Results for the vertex-wise group difference in the surface displacement (affine pre-registered) between Parkinson’s disease patients [n = 55
(UBC), n = 189 (PPMI)] and healthy controls [n = 54 (UBC), n = 137 (PPMI)] for 8 subcortical structures.
Structure UBC PD PPMI
(Total no. of vertices)
No. of p-value t-value HC group PD group No. of p-value t-value HC group PD group
vertices vertices
L-thal (2212)
145 0.001* 2.73 0.15± 0.05 0.04±0.06 159 0.000* 3.21 0.18±0.04 0.11± 0.04
111 0.008* 3.06 0.09± 0.05 −0.08±0.05 152 0.001* 3.21 0.06±0.05 −0.02± 0.04
R-thal (2146)
244 0.003* 3.32 0.57± 0.03 0.46±0.04 185 0.000* 3.27 0.48±0.05 0.43± 0.04
68 0.132 −2.53 0.11± 0.06 0.28±0.06 166 0.003* 3.47 0.31±0.04 0.23± 0.04
L-caud (2096)
62 0.023* 2.49 0.13± 0.04 0.02±0.03 88 0.008* 3.08 0.02±0.06 −0.07± 0.05
37 0.102* −2.69 −0.04± 0.01 0.03±0.02 110 0.019* −2.80 0.15±0.03 0.23± 0.03
R-caud (2116)
170 0.003* 2.84 0.09± 0.08 −0.11±0.06 306 0.000* 2.75 0.11±0.05 0.04± 0.06
176 0.004* −2.69 0.17± 0.04 0.32±0.03 152 0.004* 2.88 −0.12±0.07 −0.22± 0.07
L-pall (522)
115 0.001* 2.70 0.60± 0.03 0.55±0.03 270 0.000* 3.01 0.44±0.04 0.42± 0.04
14 0.086 2.58 0.33± 0.03 0.28±0.02 4 0.555 −2.13 0.19±0.02 0.23± 0.00
R-pall (468)
63 0.001* 2.59 0.33± 0.03 0.31±0.01 147 0.000* 3.02 0.50±0.04 0.48± 0.05
95 0.001* 2.92 0.44± 0.02 0.41±0.02 29 0.011* 3.08 0.30±0.01 0.28± 0.01
L-put (1996)
92 0.002* −2.94 −0.09± 0.03 −0.03±0.03 157 0.000* 3.19 0.28±0.07 0.21± 0.06
51 0.097 −3.00 −0.07± 0.03 0.06±0.02 67 0.032 2.51 0.10±0.02 0.05± 0.03
R-put (1974)
75 0.008* 2.48 0.15± 0.03 0.08±0.03 73 0.002* 2.58 0.30±0.07 0.26± 0.07
55 0.103 −2.65 0.07± 0.02 0.13±0.03 90 0.012 2.45 0.11±0.05 0.07± 0.04
Data presented for top 2 vertex clusters and their corresponding mean value for the t-statistic, p-value and the mean ± standard-deviation of the surface displacement in the HC and
PD group. Structures and clusters with statistically significant (p < 0.05) difference marked with an asterisk (*).
thus derived is able to accurately capture the shape alteration due
to disease. Using this metric, we were able to spatially localize the
areas with significant disease related alteration.
We found both similarities as well as differences in the
anatomical location of shape changes between the two cohorts.
The observed differences can be attributed to the difference in
scanners, image acquisition protocols, inhomogeneities due to
multi-center data collection in the PPMI cohort and differences
in clinical features. Nonetheless, there are very encouraging over-
lapping changes in the PD groups in the two cohorts, mainly in
sensorimotor and limbic areas and we will preliminarily discuss
the functional implications of these most robust changes: The
globus pallidus shows the most widespread changes with several
areas of atrophy bilaterally in both cohorts; in the two datasets,
areas of atrophy overlap along the medial aspect of the globus
pallidus internus, most likely in areas implied in motor func-
tion (Obeso et al., 2015). In the caudate, atrophy is present along
the dorso(medial) tail of the caudate on the right, affecting areas
belonging to sensorimotor, frontostriatal circuits (Redgrave et al.,
2010). On the left, fewer changes are observed, there is some over-
lap for atrophy along the ventral tail of the caudate, again likely
implying sensorimotor circuits. In the left putamen, we found
mostly hypertrophy in the UBC cohort but atrophy in the PPMI
cohort without clear areas of overlap between the groups. On the
right, areas of atrophy overlap in the dorsal area of the posterior
putamen, which is associated with sensorimotor function (Red-
grave et al., 2010). Both areas of hypertrophy and atrophy were
observed in the thalamus, atrophy with partial overlap between
the two groups is found in mediodorsal aspects of the thalami
bilaterally. The mediodorsal thalamus is part of the limbic circuit
and has been implied in depression in PD (Cardoso et al., 2009;
Li et al., 2010). The shape feature computed in our study presents
the potential to detect the differences between PD and control
groups. The discriminant function that can be developed from
this work could then be applied in longitudinal studies to see if
it is able to detect alterations in subjects in the prodromal phase
of PD.
4.3. Shape Differences and Clinical Association
The surface displacement shape feature was not able to predict
the UPDRS motor score (Figure 6). The UPDRS motor score is
a fairly crude clinical measurement as it combines different fea-
tures of PD such as tremor and postural instability which have
differing anatomical bases and this might partially explain why
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FIGURE 6 | Scatter plots for the predicted and actual clinical scores
from the leave one out prediction experiment using the PC loadings
from the PCA decomposition of surface displacements where data
from all structures was combined. Experimental data from the (A) UBC
dataset and (B) PPMI dataset. Blue line is the least squares fit between the
predicted and actual clinical score values.
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we did not find a correlation of the UPDRS motor score with
shape changes. In order to identify correlations of shape changes
with clinical indices, future studies should examine motor sub-
scores for rigidity, bradykinesia, tremor and axial stability sep-
arately, assess mood, cognitive and reward function, control for
more affected side and handedness and match groups closely for
age and gender.
4.4. Limitation and Conclusions
In our study, we considered the pre-registration of the binary seg-
mentations using rigid and affine transformations, respectively
(see Section 2.2.5). The surface displacement feature computed
from the rigid registered data did not show a statistically sig-
nificant difference between the groups (HC vs. PD), whereas,
the affine registered data showed spatial clusters with significant
difference (Table 4, Figures 4, 5). This suggests that the scale
variability among the target binary segmentations has a con-
founding effect on the CN vs. PD group differences, and the
diseases related changes are likely smaller than the variability in
the scale of the structures seen across the population. The use
of an affine pre-registration step between the binary segmenta-
tions removed the scale-related variability, however, in the pro-
cess, it may also have removed some of the scale related changes
seen due to PD. Hence, using the structures which are chang-
ing due to the disease, to further remove effects due to overall
scale change across the population is likely sub-optimal. Fur-
ther, the cross-talk between the normally occurring scale vari-
ability of structures in the population vs. the changes in scale
due to disease (such as atrophy, or hypertrophy) likely affects all
shape analysis methods that rely on surface deformation based
morphometry. This observation highlights the need for shape
assessment methods to deal with scale-related variability in the
population better. As a suggestion, perhaps accounting for scale
variability using a feature that does not change with disease such
as the cranial vault instead of the binary segmentations can be
investigated.
We applied volumetric registrationmethod to obtain themap-
pings between the source and target binary images. As the binary
images carry shape information at the boundary pixels and the
pixels in the interior contain minimal or no information regard-
ing shape of the structures, such methods are expected to provide
registration accuracy and shape information, at par with surface
registration methods. However, a direct comparison of the two
sets of methods is beyond the focus of the current work and
forms a scope for future investigation. Additionally, in order to
be used as a biomarker in the clinical setting, the method needs
to be tested further on much larger and independent data cohorts
for its ability to predict clinical features and the ability to detect
changes in the prodromal stages of the disease.
In conclusion, we present a first study to investigate the change
in shape in Parkinson’s disease tested on a large publicly avail-
able dataset (PPMI) and validated on an independently acquired
dataset at UBC. Our results suggest that systemic changes in the
shape of subcortical structures (caudate, pallidum, putamen and
thalamus) can be non-invasively assessed in PD in vivo. The sur-
face displacement feature encodes the spatially localized shape
information. In this study, we have been able to highlight regions
on the surface of subcortical structures that show changes in PD.
The automated method presented in the study provides a new
avenue to assess the progress of the neuro-degenerative processes.
Further validation using data from larger cohorts is needed to
assess the predictive capability of this method.
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